Osteosarcoma-specific delivery of CRISPR/Cas9 by aptamer-functionalized lipopolymer for therapeutic genome editing of VEGFA in a patient-derived xenograft model

Project Details

StatusActive
Effective start/end date1/01/1930/06/22